Veltri; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Veltri; Robert.The latest application filed is for "novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer".

Company Profile

0.7.5

Veltri; Robert - Oklahoma City OK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer App 20110286917 - An; Gang ; et al.	2011-11-24
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Grant 7,993,830 - An , et al. August 9, 2	2011-08-09
Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer App 20080044416 - An; Gang ; et al.	2008-02-21
Diagnosis of disease state using mRNA profiles in peripheral leukocytes Grant 7,332,270 - Ralph , et al. February 19, 2	2008-02-19
Biomarkers and targets for diagnosis, prognosis and management of prostate disease, bladder and breast cancer App 20030050470 - An, Gang ; et al.	2003-03-13
Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer App 20030017472 - An, Gang ; et al.	2003-01-23
Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer App 20020068281 - An, Gang ; et al.	2002-06-06
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Grant 6,369,195 - An , et al. April 9, 2	2002-04-09
Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer Grant 6,218,529 - An , et al. April 17, 2	2001-04-17
Diagnosis of disease state using MRNA profiles in peripheral leukocytes Grant 6,190,857 - Ralph , et al. February 20, 2	2001-02-20
Biomarkers and targets for diagnosis, prognosis and management of prostate disease Grant 5,882,864 - An , et al. March 16, 1	1999-03-16
Pharmaceutically useful Michael addition products of unsaturated aldehydes and ketones and ascorbic acid Grant 5,098,933 - Veltri , et al. March 24, 1	1992-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.